Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew R Hallahan

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Trends in Molecular Medicine|April 23, 2004
p38 MAP kinase: a convergence point in cancer therapyJames M Olson, Andrew R Hallahan
Neural Development|October 19, 2010
RBP-J is not required for granule neuron progenitor development and medulloblastoma initiated by Hedgehog pathway activation in the external germinal layerElaine Julian, Andrew R Hallahan, Brandon J Wainwright
Theoretical Biology & Medical Modelling|April 11, 2006
A statistical method for predicting splice variants between two groups of samples using GeneChip expression array dataWenhong Fan, Najma Khalid, Andrew R Hallahan, et al.
Molecular Cancer Therapeutics|September 27, 2012
Targeting the inhibitor of apoptosis proteins as a novel therapeutic strategy in medulloblastomaJoanna Keating, Maria Tsoli, Andrew R Hallahan, et al.
Pediatric Blood & Cancer|April 10, 2015
The outcomes and treatment burden of childhood acute myeloid leukaemia in Australia, 1997-2008: A report from the Australian Paediatric Cancer RegistrySteven A Foresto, Danny R Youlden, Peter D Baade, et al.
Cancer Epidemiology|March 15, 2015
Conditional survival estimates for childhood cancer in Australia, 2002-2011: A population-based studyDanny R Youlden, Peter D Baade, Andrew R Hallahan, et al.
Leukemia Research|February 10, 2015
Targeting survivin with YM155 (Sepantronium Bromide): a novel therapeutic strategy for paediatric acute myeloid leukaemiaAmanda M Smith, Erica B Little, Andjelija Zivanovic, et al.
Experimental Hematology & Oncology|November 14, 2013
ABC transporter activity linked to radiation resistance and molecular subtype in pediatric medulloblastomaWendy J Ingram, Lisa M Crowther, Erica B Little, et al.
Nature Medicine|July 23, 2003
BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effectAndrew R Hallahan, Joel I Pritchard, Roshantha A S Chandraratna, et al.
The Medical Journal of Australia|February 11, 2009
Haemopoietic stem cell transplantation for children in Australia and New Zealand, 1998-2006: a report on behalf of the Australasian Bone Marrow Transplant Recipient Registry and the Australian and New Zealand Children's Haematology Oncology GroupAndrew S Moore, Peter J Shaw, Andrew R Hallahan, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Trends in Molecular Medicine|April 23, 2004
p38 MAP kinase: a convergence point in cancer therapyJames M Olson, Andrew R Hallahan
Neural Development|October 19, 2010
RBP-J is not required for granule neuron progenitor development and medulloblastoma initiated by Hedgehog pathway activation in the external germinal layerElaine Julian, Andrew R Hallahan, Brandon J Wainwright
Theoretical Biology & Medical Modelling|April 11, 2006
A statistical method for predicting splice variants between two groups of samples using GeneChip expression array dataWenhong Fan, Najma Khalid, Andrew R Hallahan, et al.
Molecular Cancer Therapeutics|September 27, 2012
Targeting the inhibitor of apoptosis proteins as a novel therapeutic strategy in medulloblastomaJoanna Keating, Maria Tsoli, Andrew R Hallahan, et al.
Pediatric Blood & Cancer|April 10, 2015
The outcomes and treatment burden of childhood acute myeloid leukaemia in Australia, 1997-2008: A report from the Australian Paediatric Cancer RegistrySteven A Foresto, Danny R Youlden, Peter D Baade, et al.
Cancer Epidemiology|March 15, 2015
Conditional survival estimates for childhood cancer in Australia, 2002-2011: A population-based studyDanny R Youlden, Peter D Baade, Andrew R Hallahan, et al.
Leukemia Research|February 10, 2015
Targeting survivin with YM155 (Sepantronium Bromide): a novel therapeutic strategy for paediatric acute myeloid leukaemiaAmanda M Smith, Erica B Little, Andjelija Zivanovic, et al.
Experimental Hematology & Oncology|November 14, 2013
ABC transporter activity linked to radiation resistance and molecular subtype in pediatric medulloblastomaWendy J Ingram, Lisa M Crowther, Erica B Little, et al.
Nature Medicine|July 23, 2003
BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effectAndrew R Hallahan, Joel I Pritchard, Roshantha A S Chandraratna, et al.
The Medical Journal of Australia|February 11, 2009
Haemopoietic stem cell transplantation for children in Australia and New Zealand, 1998-2006: a report on behalf of the Australasian Bone Marrow Transplant Recipient Registry and the Australian and New Zealand Children's Haematology Oncology GroupAndrew S Moore, Peter J Shaw, Andrew R Hallahan, et al.
Pageof 3